$MRVL

MRVL Maintained by UBS -- Price Target Raised to $350

UBS maintained a 'Buy' rating for Marvell Technology (MRVL) and raised its price target to $350 from $335. The stock is currently trading at $284.68, which GuruFocus deems 131.6% overvalued. Marvell has a GF Score of 74/100, with strong growth and financial strength but poor valuation metrics. Insider selling totaled $13.27M over the last three months.

Original reporting
Published Oct 7, 2026, 9:33 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 8, 2026, 7:15 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$MRVL
Bullish
medium confidence
Mentioned
$MRVL
Relevance
7/10
AlphAI data visualization · based on gurufocus.com
Decision brief

The 30-second read

$MRVLBullishMed
01

Why it matters

UBS's target increase reflects optimism on AI‑driven data infrastructure demand, but valuation metrics remain a concern.

02

Market read

Analyst target raise provides a fresh catalyst for MRVL, potentially influencing short‑term price action and sector sentiment.

03

What to watch

High insider sell volume and GF Value overvaluation metric suggest caution despite the target raise.

Relevance 7/10Novelty 6/10Timing: Oct 7, 2026 (same day release)

Background

Marvell Technology is a fabless semiconductor firm serving data centers, networking, and automotive markets.

Company-level read

Ticker impact

$MRVLBullishMedium confidence
Context

UBS raised its price target for Marvell Technology to $350 and maintained a Buy rating, providing fresh analyst guidance.

Expected impact

likely upward pressure as investors price in the higher target

Evidence & confidence

Analyst upgrade with a concrete target change is a fresh catalyst, but valuation concerns limit the upside.

Market effects

May lift sentiment in the broader semiconductor sector as analysts show confidence in data‑infrastructure demand.

Limited to U.S. and global tech investors tracking semiconductor stocks.

Modest; primarily affects Marvell and peers watching analyst target revisions.

Counterpoint

Valuation appears stretched (P/E ~94) and insider selling could signal downside risk.

Key entities

  • Marvell Technology

    Fabless semiconductor company (ticker MRVL).

  • UBS

    Investment bank providing the rating update.

Related articles

$MUMed

Memory Trade: Cyclical or Durable Growth?

Micron (MU) and SanDisk (SNDK) have surged due to AI-driven demand, with gains of 953% and 3,398.70% over two years. Despite strong earnings and guidance, both stocks have recently stagnated amid debates over cyclicality. DA Davidson raised Micron's price target to $3,000, citing investor sentiment. Analysts expect Micron's earnings to rise 699% next quarter, with supply constraints lasting until 2027. Both stocks have a P/E of 13.85x.

$MRVLMed

Marvell Shares Slip in Premarket as Investors Lock In Gains After Investor Day Surge

Marvell Technology (MRVL) shares fell 2% in premarket trading after a 6% surge on Tuesday, when the company projected revenue could reach $90B by 2031. Analysts adjusted price targets, with Needham raising to $400 and Cantor Fitzgerald to $350. The company aims to capture AI and data center infrastructure spending, with a total addressable market of $400B by 2030. Marvell's stock has gained 240% in 2026, trading at a P/E of 89.8.

$MRVLHighAI 8/10

Marvell price target raised by Bank of America on $80 billion sales outlook

Bank of America raised Marvell Technology's price target to $400 from $365, maintaining a 'buy' rating. The company projects 2030 sales of $70B-$90B, with a midpoint of $80B, and raised its 2027 revenue target by 10% to $20B. BofA also increased its EPS forecasts for 2028 and 2029 by 15% and 26%, respectively. Marvell sees a $400B total addressable market by 2030, up from $104B in 2028.